TY - JOUR
T1 - Gastrointestinal amyloidosis in a patient with systemic sclerosis
AU - Chiu, Yu Hsiang
AU - Chen, Peng Jen
AU - Chang, Yi Ming
AU - Hou, Tsung Yun
N1 - Publisher Copyright:
© 2017 Journal of Medical Sciences.
PY - 2017
Y1 - 2017
N2 - There were more than 90% of systemic sclerosis (SSc) patients developing gastrointestinal tract involvement with affecting esophagus mostly. However, a typical gastrointestinal manifestation may be not the only result of SSc. We described a 70-year-old female with SSc presented poor appetite, intermittent heartburn sensation, nausea, frequent sensation of abdominal fullness, and intermittent dull pain for 2 months. The esophagogastroduodenoscopy showed gastrointestinal as gastroesophageal reflux disease. The biopsy revealed amorphous material deposited in the vascular walls and apple-green birefringence in a polarization examination with Congo red staining which proved amyloidosis. The SSc patient with gastrointestinal involvement suggests to receive esophagogastroduodenoscopy, and a biopsy may be helpful to these patients to examine the possibility of secondary amyloidosis. These patients need more aggressively disease activity control.
AB - There were more than 90% of systemic sclerosis (SSc) patients developing gastrointestinal tract involvement with affecting esophagus mostly. However, a typical gastrointestinal manifestation may be not the only result of SSc. We described a 70-year-old female with SSc presented poor appetite, intermittent heartburn sensation, nausea, frequent sensation of abdominal fullness, and intermittent dull pain for 2 months. The esophagogastroduodenoscopy showed gastrointestinal as gastroesophageal reflux disease. The biopsy revealed amorphous material deposited in the vascular walls and apple-green birefringence in a polarization examination with Congo red staining which proved amyloidosis. The SSc patient with gastrointestinal involvement suggests to receive esophagogastroduodenoscopy, and a biopsy may be helpful to these patients to examine the possibility of secondary amyloidosis. These patients need more aggressively disease activity control.
KW - Amyloidosis
KW - Gastroesophageal reflux disease
KW - Systemic sclerosis
UR - http://www.scopus.com/inward/record.url?scp=85022192451&partnerID=8YFLogxK
U2 - 10.4103/jmedsci.jmedsci_64_16
DO - 10.4103/jmedsci.jmedsci_64_16
M3 - Article
AN - SCOPUS:85022192451
SN - 1011-4564
VL - 37
SP - 117
EP - 119
JO - Journal of Medical Sciences (Taiwan)
JF - Journal of Medical Sciences (Taiwan)
IS - 3
ER -